Bio Impact Capital LLC has filed its 13F form on May 15, 2025 for Q1 2025 where it was disclosed a total value porftolio of $540 Million distributed in 43 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Cullinan Oncology, Inc. with a value of $57.9M, Madrigal Pharmaceuticals, Inc. with a value of $33.3M, Zai Lab LTD with a value of $30.1M, Edgewise Therapeutics, Inc. with a value of $24.3M, and Lantheus Holdings, Inc. with a value of $22.7M.

Examining the 13F form we can see an decrease of $128M in the current position value, from $669M to 540M.

Bio Impact Capital LLC is based out at Cambridge, MA

Below you can find more details about Bio Impact Capital LLC portfolio as well as his latest detailed transactions.

Portfolio value $540 Million
Healthcare: $540 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 43
  • Current Value $540 Million
  • Prior Value $669 Million
  • Filing
  • Period Q1 2025
  • Filing Date May 15, 2025
  • Form Type 13F-HR
  • Activity in Q1 2025
  • New Purchases 6 stocks
  • Additional Purchases 26 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 8 stocks
Track This Portfolio

Track Bio Impact Capital LLC Portfolio

Follow Bio Impact Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bio Impact Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bio Impact Capital LLC with notifications on news.